|
Health problem and current use of the technology (CUR)
|
5 (4,5)
|
24
|
| |
Target population
| | |
|
A0007
|
What is the target population in this assessment?
|
5 (4,5)
|
24
|
|
A0023
|
How many people belong to this target population
|
5 (3.75, 5)
|
24
|
| |
Target condition
| | |
|
A0002
|
What is the health condition
|
5 (4,5)
|
24
|
|
A0003
|
What are the known risk factors?
|
5 (4,5)
|
24
|
|
A0004
|
What is the natural course of the health condition?
|
4 (4,5)
|
23
|
|
A0005
|
What are the symptoms or health condition for the patient?
|
4 (4,5)
|
24
|
|
A0006
|
What are the consequences of the health condition for the society?
|
4.5 (4,5)
|
22
|
|
A0009
|
What aspects of the consequences are targeted by the Umbiflow?
|
4 (4,5)
|
23
|
| |
Current management of the condition
| | |
|
A0018
|
What are the other typical or common alternatives to the Umbiflow?
|
4 (3.5,5)
|
23
|
|
A0024
|
How is the health condition currently diagnosed according to published guidelines and in practice?
|
4 (4,5)
|
24
|
|
A0025
|
How is the health condition currently managed according to published guidelines and in practice?
|
4 (4,5)
|
24
|
| |
Utilization
| | |
|
A0001
|
For which health conditions and populations, and for what purposes is the technology used?
|
4 (3,5)
|
24
|
|
A0011
|
How much are the technologies utilized?
|
4 (3,5)
|
24
|
|
F0001
|
Is Umbiflow a new, innovative mode of care, an add-on to, or modification of a standard mode of care, or a replacement of a standard mode of care?
|
4 (3,5)
|
24
|
|
Description and technical characteristics of technology (TEC)
|
4 (3,5)
|
24
|
|
Safety (SAF)
|
5 (4,5)
|
24
|
| |
Patient safety
| | |
|
C0006
|
What are the consequences of false positive, false negative and incidental findings generated by using the technology from the viewpoint of patient safety?
|
4 (3,5)
|
24
|
|
Clinical effectiveness (EFF)
|
4 (4,5)
|
23 (95.8)
|
| |
Mortality
| | |
|
D0001
|
What is the expected beneficial effect of intervention on mortality?
|
4 (4,5)
|
24
|
| |
Morbidity
| |
|
D0005
|
How does using Umbiflow affect findings of the health condition?
|
4 (4,5)
|
24
|
|
D1004
|
What are the requirements for accuracy in the context where the technology will be used?
|
4 (3,5)
|
24
|
| |
Change-in-management
| |
|
D0020
|
Does use of the test lead to improved detection of the condition?
|
4 (4,5)
|
24
|
|
D0010
|
How does the technology modify the need for hospitalisation?
|
4 (3,5)
|
24
|
| |
Benefit-harm balance
| |
|
D0029
|
What are the overall benefits and harms of the technology in health outcomes?
|
4 (3,5)
|
24
|
|
Costs and Economic aspect
|
4 (3.4,5)
|
24
|
| |
Process-related costs
| | |
|
G0006
|
What are the costs of processes related to acquisition and setting up new technology?
|
4 (3,5)
|
23
|
|
G0007
|
What are the likely budget impacts of implementing the technology?
|
4 (3,5)
|
23
|
|
Ethical aspect
|
4 (4,5)
|
24
|
| |
Autonomy
| | |
|
F0006
|
Is there a need for any specific interventions or supportive actions concerning information in order to respect patient autonomy when the technology is used?
|
4 (3.5,5)
|
23
|
|
F0007
|
Does the implementation or withdrawal of the technology challenge or change professional values, ethics or traditional roles?
|
4 (3,4.5)
|
23
|
| |
Legislation
| | |
|
F0014
|
Does the implementation or use of the technology affect the realisation of basic human rights?
|
4 (3,5)
|
23
|
|
Organizational aspect
|
4 (3,5)
|
24
|
| |
Health delivery process
| | |
|
G0001
|
How does the technology affect the current work processes?
|
4 (3,5)
|
24
|
|
G0100
|
What kind of patient/participant flow is associated with the new technology?
|
4 (3,5)
|
24
|
|
G0002
|
What kind of involvement has to be mobilised for patients/participants and important others and/or caregivers?
|
4 (3,5)
|
21
|
|
G0003
|
What kind of process ensures proper education and training of staff?
|
4 (3,5)
|
23
|
| |
Management
| | |
|
G0008
|
What management problems and opportunities are attached to the technology?
|
4 (3,5)
|
24
|
|
Patient and social aspect
|
4 (4,5)
|
23 (95.8)
|
| |
Patient’s perspectives
| | |
|
H0100
|
What expectations and wishes do patients have with regard to the technology and what do they expect to gain from the technology?
|
4 (3,5)
|
24
|
| |
Communication aspects
| | |
|
H0202
|
How are treatment choices explained to patients?
|
4 (3,5)
|
24
|
|
Legal aspect
|
4 (3.5,5)
|
23 (95.8)
|
| |
Autonomy of the patient
| | |
|
I0034
|
Who is allowed to give consent for minors and incompetent persons?
|
4 (3,5)
|
24
|
| |
Privacy of the patient
| | |
|
I0009
|
What do laws/binding rules require with regard to appropriate measures for securing patient data and how should this be addressed when implementing the technology?
|
4 (3.75,4.25)
|
24
|
